Oxaliplatin | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Oxaliplatin
Canada

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

Oxaliplatin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

54 API Suppliers, 25 USDMF, 29 CEP/COS, 8 JDMF, 8 EU WC, 25 KDMF, 10 NDC API, 27 Listed Suppliers, $ API Reference Price

54 API Suppliers
25 USDMF
29 CEP/COS
8 JDMF
8 EU WC
25 KDMF
10 NDC API
27 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

108 Drugs in Development

108 Drugs in Development

INTERMEDIATES

8 Intermediates Suppliers

8 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

219 FDF Dossiers, 67 FDA Orange Book, 80 Europe, 5 Canada, 4 Australia, 20 South Africa, 43 Listed Dossiers

219 FDF Dossiers
67 FDA Orange Book
80 Europe
5 Canada
4 Australia
20 South Africa
43 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML), INJECTABLE;INTRAVENOUS - 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML), INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML), INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML)

INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML)
INJECTABLE;INTRAVENOUS - 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML)
INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML)
INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML)

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Capital Farma, 2 DFE Pharma, 14 Kerry, 2 Microlex e.U, 1 Pluviaendo, 2 Sigachi Industries

1 SPI Pharma
1 Faran Shimi Pharmaceutical
3 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Capital Farma
2 DFE Pharma
14 Kerry
2 Microlex e.U
1 Pluviaendo
2 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

20 Fillers, Diluents & Binders, 7 Direct Compression, 4 Co-Processed Excipients, 4 Granulation, 2 Solubilizers, 1 Parenteral

20 Fillers, Diluents & Binders
7 Direct Compression
4 Co-Processed Excipients
4 Granulation
2 Solubilizers
1 Parenteral

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 36 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
36 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 59 Finished Drug Prices, 7 Annual Reports

1 US Medicaid Prescriptions
59 Finished Drug Prices
7 Annual Reports

MARKET PLACE

6 APIs, 18 FDF Dossiers

6 APIs
18 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 7 USP, 7 Others

5 EDQM
7 USP
7 Others

$ API Ref.Price (USD/KG) : 35,910 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 1DR REDDY'S LABORATORIES LTD

02 1FRESENIUS KABI CANADA LTD

03 1PFIZER CANADA ULC

04 1SANDOZ CANADA INCORPORATED

05 1TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

5 All

01 5OXALIPLATIN

filter Dosage Form Reset all filters

5 All

01 5SOLUTION

filter Brand Name Reset all filters

5 All

01 1OXALIPLATIN

02 2OXALIPLATIN INJECTION

03 2OXALIPLATIN INJECTION, USP

List of Suppliers

Product Main Page

01

FRESENIUS KABI CANADA LTD

Austria

PharmaVenue

Not Confirmed

FRESENIUS KABI CANADA LTD

Austria

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Austria

Digital Content

Regulatory Info :

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN INJECTION, USP

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/40ML

Approval Date :

Application Number : 2457423

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

PFIZER CANADA ULC

PharmaVenue

Not Confirmed

PFIZER CANADA ULC

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/40ML

Approval Date :

Application Number : 2444763

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

03

SANDOZ CANADA INCORPORATED

PharmaVenue

Not Confirmed

SANDOZ CANADA INCORPORATED

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN INJECTION

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/30/40ML

Approval Date :

Application Number : 2436957

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

04

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN INJECTION

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/40ML

Approval Date :

Application Number : 2435071

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

DR REDDY'S LABORATORIES LTD

Country

PharmaVenue

Not Confirmed

DR REDDY'S LABORATORIES LTD

Country

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN INJECTION, USP

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/40ML

Approval Date :

Application Number : 2458403

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?